Ocular Melanoma — Trials

Ocular Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

254 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 62
Recruiting: 32
Ph III recruiting: 6
Growth YoY: —
Industry share: 35%
Top sponsor: IDEAYA Biosciences
Termination share: 31.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (36)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07804186	Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma	recruiting	Phase 3	450	IDEAYA BiosciencesINDUSTRY	2	Sep 15, 2026	clinicaltrials
NCT06246149	Adjuvant Tebentafusp in High Risk Ocular Melanoma(ATOM)	recruiting	Phase 3	290	European Organisation for Research and Treatment of Cancer - EORTCNETWORK	9	Jun 30, 2026